How one company is trying to disrupt drug pricing

Alexis Borisy, founder and CEO of EQRx, joins CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference in San Francisco to discuss the company's goal of undercutting the price of branded drugs.
Mon, Jan 13 20208:26 AM EST